CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in KRYS — Krystal Biotech, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$94,711,922
+$32,202,099 QoQ
Shares Held
254,828
+5.3% QoQ
Ownership
0.861%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. KRYS ranks #19 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,711,922 | 254,828 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,509,823 | 241,986 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $59,853,501 | 242,774 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $42,872,605 | 242,863 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $33,839,902 | 246,180 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $45,167,674 | 250,514 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $38,095,012 | 243,170 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $43,726,518 | 240,216 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $40,481,417 | 220,439 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $33,611,510 | 188,903 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,955,814 | 185,038 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $20,854,480 | 179,780 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,038,288 | 162,166 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $12,800,713 | 159,889 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,723,920 | 160,615 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,892,088 | 156,271 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,767,056 | 148,752 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,871,009 | 148,347 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,766,279 | 139,618 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,546,298 | 125,384 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,300,896 | 122,072 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,821,465 | 114,505 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,950,740 | 99,179 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,162,762 | 96,696 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,170,618 | 76,548 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,979,365 | 68,903 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||